Kaposi’s varicelliform eruption in a patient with metastatic melanoma and primary cutaneous anaplastic large cell lymphoma treated with talimogene laherparepvec and nivolumab [PDF]
Journal for ImmunoTherapy of Cancer, 2018 Background Immune-directed therapies have become front-line therapy for melanoma and are transforming the management of advanced disease. In refractory cases, multi-modal immunoncology (IO) approaches are being utilized, including combining immune ...
David M. Miller +3 more
doaj +2 more sources
Kaposi varicelliform eruption (eczema herpeticum)
Dermatology Online Journal, 2008 A 35-year-old woman with a history of atopic diathesis presented to the emergency department with 2 weeks of widespread facial vesiculopustules and eroded vesicles. HSV-1 was found on viral culture and direct fluorescent antibody testing. She was diagnosed with eczema herpeticum, an uncommon and potentially life-threatening viral infection that arises ...
Olson, Jonathan +3 more
core +6 more sources
Multiple painful vesicles in a patient with erythroderma [PDF]
JAAD Case Reports, 2023 Ricardo Torres-Delgadillo, MD +4 more
doaj +2 more sources
Kaposi varicelliform eruption in a patient with epidermolysis bullosa simplex generalized severe [PDF]
JAAD Case Reports, 2016 Laurent Misery, Sylvie Fraitag
exaly +2 more sources
Severe Eczema Herpeticum With Ocular Involvement Leading to Orbital Cellulitis: A Pediatric Case Report. [PDF]
Case Rep Dermatol MedEczema herpeticum (EH) is a superimposed cutaneous viral infection that occurs in the context of preexisting dermatoses, most commonly atopic dermatitis (AD). It typically involves the face, neck, and upper trunk. Although ocular involvement is relatively uncommon, it may present diagnostic and therapeutic challenges and pose a significant risk to ...
Chew CH +3 more
europepmc +2 more sources
Algorithms in Allergy: Diagnosis and Treatment of Atopic Dermatitis Complicated by Eczema Herpeticum. [PDF]
AllergyAllergy, Volume 80, Issue 8, Page 2417-2420, August 2025.
Traidl S, Heratizadeh A, Werfel T.
europepmc +2 more sources
Efgartigimod-associated Kaposi’s varicelliform eruption and herpetic conjunctivitis in a patient with seropositive ocular myasthenia gravis: a case report and review [PDF]
Frontiers in ImmunologyGe L +6 more
exaly +2 more sources
Infection risk with JAK inhibitors in dermatoses: a meta-analysis. [PDF]
Int J DermatolAbstract Evolving evidence suggests that Janus Kinase Inhibitors (JAKi) may predispose to certain infections, including tuberculosis and human herpes viruses. This review aimed to compare the infection risk in patients on a systemic JAKi for a dermatologic indication to a placebo.
Ireland PA +4 more
europepmc +2 more sources
Plasmapheresis for Facilitating Readministration of Rituximab After Paradoxical Exacerbation in Pemphigus Vulgaris: A Case Report. [PDF]
Clin Case RepABSTRACT Rare reports of post‐rituximab exacerbation of pemphigus vulgaris (PV) have been published, with some therapeutic protocols proposed for managing this condition. A 40‐year‐old female with PV experienced an exacerbation of mucocutaneous lesions following rituximab administration.
Pourani MR +4 more
europepmc +2 more sources
Journal of the European Academy of Dermatology and Venereology, Volume 37, Issue 9, Page 1871-1880, September 2023., 2023 Abstract Background Atopic dermatitis (AD) is a heterogeneous inflammatory skin disease with different clinical phenotypes based on factors such as age, race, comorbidities, and clinical signs and symptoms. The effect of these factors on therapeutic responses in AD has only been scarcely studied and not for upadacitinib.
J. P. Thyssen +16 more
wiley +1 more source